Researchers suggest targeting ECM-mediated regulation of autophagy levels could be used to sensitize pancreatic cancer to FDA-approved therapies.
In a landmark decision this week, European Union defence ministers approved national plans worth roughly €75 billion under the bloc’s new €150 billion ...